Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Bausch, Biocardia, Biomx, Chimed, Dicerna, Eyegate, Genfit, GT Biopharma, Iterum, Kiniksa, Matinas, Mersana, Mimetogen, Orphomed, Proqr, Reata, Synairgen, Verona, Xenon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Medtronic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Aveo, Axsome, Biohaven, Cabaletta, Can-Fite, Cohbar, Cytodyn, Eagle, Faron, Immunovant, Inovio, Intensity, Mediwound, Opthea, Ovid, Oyster, Phasebio, Polyphor, Pluristem, Regeneron, Resverlogix, Revive, Sanofi, Symbio, Synlogic, Seres, Tcr2, Zealand.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altasciences, Arbutus, Translate Bio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: BMS, Bolt, Decibel, Healios, Imcheck, Inovio, Ipsen, Ironwood, Medimetriks, Oncopeptides, Otsuka, Qurient, Tolero, Uniqure, VBL.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allakos, Avadel, Cassava, Diffusion, Eloxx, Immutep, Lundbeck, Mind Medicine, Onconova, Opko.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Genentech, Humanigen, Immutep, Inxmed (Shanghai) Co., Recce.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Radlogics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aravive, Avexis, Fulcrum, Leading Biosciences, Milestone, Novartis, Novavax, Oncolytics, Oncopeptides, Oncoquest, Partner, Rafael, Seelos.